Frequency distributions of plasma apolipoprotein (a) levels and phenotypes: A comparison between southern and northern Chinese populations

Chinese Medical Journal

Volumn 110, Issue 6, 1997, Pages 465-473

  Pang, Richard Wing Cheung ^a,c   Chen, Baosheng ^b   Janus, Edward Denis ^a   Lam, Karen Siuling ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^c QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A;

ADULT; AGED; ARTICLE; BLOOD; CHINA; COMPARATIVE STUDY; FEMALE; GENETIC POLYMORPHISM; GENETICS; HONG KONG; HUMAN; MALE; MASS SCREENING; MIDDLE AGED; PHENOTYPE;

ADULT; AGED; APOLIPOPROTEINS A; CHINA; FEMALE; HONG KONG; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, GENETIC;

EID: 0031152013     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Berg K. A new serum type system in man: the Lp system. Acta Pathol Microbiol Scand 1963; 59:369.
2. McLean JW, Tomlinson JE, Kuang WJ, et al. cDNA sequence of human apolipoprotein(a) is Homologous to plasminogen. Nature 1987; 330:132.
3. Gaw A, Hobbs HH. Molecular genetics of lipoprotein(a): new pieces to the puzzle. Curr Opin Lipidol 1994; 5:149.
4. Lackner C, Cohen JC, Hobbs HH. Molecular definition of the extreme size polymorphism in apolipoprotein (a). Hum Mol Genet 1993; 2:933.
5. Cohen JC, Chiesa G, Hobbs HH. Sequence polymorphisms in the apolipoprotein (a) gene. J Clin Invest 1993; 91:1630.
6. Kraft HG, Köchl S, Menzel H, et al. The apolipoprotein (a) gene: a transcribed hypervariable locus controlling plasma lipoprotein(a) concentration. Hum Genet 1992; 90:220.
7. Lackner C, Boerwinkle E, Leffert CC, et al. Molecular basis of apolipoprotein(a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresis. J Clin Invest 1991; 87:2153.
8. Morrisett JD, Gaubatz JW, Knwpp RD, et al. Structural properties of apo(a) : a major apoprotein of human lipoprotein(a). In: Scanu AM, ed. Lipoprotein(a). San Diego, California: Academic Press, 1990:53-74.
9. Walton KW, Hitchins J, Magnani HN, et al. A study of methods of identification and estimation of Lp(a) lipoprotein and its significance in health, hyperlipidaemia and atherosclerosis. Atherosclerosis 1974; 20:323.
10. Dahlen G, Frick MH, Berg K, et al. Further studies of Lp(a) lipoprotein/prel-lipoprotein in patients with coronary heart disease. Clin Genet 1975; 8:183.
11. Kostner GM, Avogaro P, Cazzolato G, et al. Lipoprotein Lp(a) and the risk for myocardial infarction. Atherosclerosis 1981; 38:51.
12. Zenker G, Koltringer P, Bone G, et al. Lipoprotein(a) as a strong indicator for cerebrovascular disease. Stroke 1986; 17:942.
13. Kraft HG, Lingenhel A, Köchl S, et al. Apolipoprotein (a) kringle IV repeat number predicts risk for coronary heart disease. Arterioscler Thromb 1996; 16:713.
14. Woo J, Lau E, Lam CWK, et al. Hypertension, lipoprotein(a), and apolipoprotein A-I as risk factors for stroke in the Chinese. Strok 1991; 22:203.
15. Scanu AM. Structural and functional polymorphism of lipoprotein (a): biological and clinical implications. Clin Chem 1995; 41:170.
16. Bowden JF, Pritchard PH, Hill JS, et al. Lp(a) concentration and apo(a) isoform size: relation to the presence of coronary artery disease in familial hypercholesterolemia. Arterioscler Thromb 1994; 14:1561.
17. Ridker PM. An epidemiologic reassessment of lipoprotein (a) and atherothrombotic risk. Trends Cardiovasc Med 1995; 5:225.
18. Sandholzer C, Sara N, Kark JD, et al. Apo(a) isoforms predict risk for coronary heart disease: a study in six populations. Arterioscler Thromb 1992; 12:1214.
19. Mbewu AD, Durrington PN. Lipoprotein(a): structure, properties and possible involvement in thrombogenesis and atherogenesis. Atherosclerosis 1990; 85:1.
20. Utermann G, Duba C, Menzel HJ. Genetics of the quan titalive Lp(a) lipoprotein trait (Part H): inheritance of Lp(a) glycoprotein phenotypes. Hum Genet 1988; 78:47.
21. Utermann G, Kraft HG, Menzel HI, et al. Genetics of the quantitative Lp (a) lipoprotein trait (Part I): relation of Lp(a) glycolipoprotein phenotypes to Lp(a) lipoprotein concentrations in plasma. Hum Genet 1988; 78:41.
22. Scanu AM, Fless GM. Lipoprotein (a): heterogeneity and biological relevance. J Clin Invest 1990; 85:1709.
23. Boerwinkle E, Leffert CC, Lin J, et al. Apolipoprotein (a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J Clin Invest 1992; 90:52.
24. Berglund L. Diet and drug therapy for lipoprotein (a). Curr Opin Lipidol 1995; 6:48.
25. Gault MH, Longerich LL, Purchase L, et al. Comparison of Lp(a) concentration and some potential effects in hemodialysis, CAPD, transplantation, and control groups, and review of the literature. Nephron 1995; 70:155.
26. Haffner SM. Lipoprotein (a) and diabetes: an update. Diabetes Care 1993; 16:835.
27. Lam KSL, Pang RWC, Janus ED, et al. Serum apolipoprotein(a) correlates with growth hormone levels in Chinese patients with acromegaly. Atherosclerosis 1993; 104:183.
28. Kung AWC, Pang RWC, Lauder I, et al. Changes in serum lipoprotein (a) and lipids during treatment of hyperthyroidism. Clin Chem 1995; 41:226.
29. Kung AWC, Pang RWC, Janus ED. Elevated serum lipoprotein(a) in subclinical hypothyroidlsm. Clin Endocrin 1995; 43:445.
30. Eden S, Wiklund O, Oscarsson J, et al. Growth hormone treatment of growth hormone-deficient adults results in a marked increase in Lp(a) and HDL cholesterol concentrations. Arterioscler Thromb 1993; 13:296.
31. Hoppichler F, Sandholzer C, Moncayo R, et al. Thyroid hormone (fT4) reduces lipoprotein(a) plasma levels. Atherosclerosis 1995; 115:65.
32. Seed M. Lipoprotein (a): its role in cardiovascular disease. In: Betteridge DJ, ed. Lipids: current perspectives-lipids and lipoproteins (Vol. 1). London: Martin Dunitz, 1996:69-88.
33. Scanu AM. Lipoprotein(a): a genetic risk factor for premature coronary heart disease. JAMA 1992; 267:3326.
34. Farrer M, Game FL, Albers CJ, et al. Coronary artery disease is associated with increased lipoprotein (a) concentrations independent of the size of circulating apolipoprotein(a) isoforms. Arterioscler Thromb 1994; 14:1272.
35. Kamboh MI, Ferrell RE, Kottke BA. Expressed hypervariable polymorphism of apolipoprotein (a). Am J Hum Genet 1991; 49:1063.
36. Kraft HG, Lingenhel A, Bader G, et al. The relative electrophoretic mobility of apo(a) isoforms depends on the gel system: proposal of a nomenclature for apo (a) phenotypes. Atherosclerosis 1996; 125:53.
37. Gaubatz JW, Ghanem KI, Guevara J Jr, et al. Polymorphic forms of human apolipoprotein (a): Inheritance and relationship of their molecular weights to plasma levels of hpoprotein (a). J Lipid Res 1990; 31:603.
38. Craig WY, Foulin SE, Ledue TB, et al. Apolipoprotein (a): a comparison of isoforms identified by sodium dodecyl sulfatepolyacrylamide gel electrophoresis or by dodecyl sulfate-agarose gel electrophoresis. Elecirophoresis 1993; 14:1038.
39. Islam S, Gutin B, Smiths C, et al. Association of apolipoprotein (a) phenotypes in Children with family history of premature coronary artery disease. Arterioscler Thromb 1994; 14:1609.
40. Sandholzer C, Hallman DM, Saha N, et al. Effects of the apolipoprotein(a) size polymorphism on the lipoprotein(a) concentration in 7 ethnic groups. Hum Genet 1991; 86:607.
41. Gaw A, Boerwinkle E, Cohen JC, et al. Comparative analysis of the apo(a) gene, apo(a) glycoprotein, and plasma concentrations of Lp(a) in three ethnic groups : evidence for no common "null" allele at the apo(a) locus. J Clin Invest 1994; 93:2526.
42. Kraft HG, Lingenhel A, Pang RWC, et al. Frequency distributions of apolipoprotein(a) kringle IV repeat alleles and their effects on Hpoprotein (a) levels in Caucasian, Asian, and African populations: the distribution of null alleles is non-random. Eur J Hum Genet 1996; 4:74.
43. Kikuchi S, Nakagawa A, Kobayashi K, et al. High degree of genetic polymorphism in apolipoprotein(a) associated with plasma lipoprotein(a) levels in Japanese and Chinese populations. Hum Genet 1993; 92:537.
44. Albers JJ, Adolphson JL, Hazzard WR. Radioimmunoas-say of human plasma Lp(a) lipoprotein. J Lipid Res 1977; 18:331.
45. Abe A, Maeda S, Makino K. Enzyme-linked immunosorbent assay of lipoprotein(a) in serum and cord blood. Clin Chim Acta 1988 ; 177:31.
46. Zhuang YY, Wang JJ, Xu P. Increased lipoprotein(a) as an independent risk factor for cardiovascular and cerebrovascular diseases. Chin Med J 1993; 106:597.
47. Zhuang YY, Li JJ, Wang JJ. Apolipoprotein(a) pheno types in cardio-cerebrovascular diseases. Chem Phys Lipids 1994; 67/68:293.
48. Lyu LC, Shieh MJ, Ordovas JM, et al. Plasma lipoprotein and apolipopiotein levels in Taipei and Framingham. Arterioscler Thromb 1993 ; 13:1429.
49. Wu JH, Kao JT, Wen MS, et al. Coronary artery disease risk predicted by plasma concentration of high-density lipoprotein cholesterol, apolipoprotein AI, apolipoprotein B, and lipoprotein(a) in a general Chinese population. Clin Chem 1993; 39:209.
50. Sandhoker C, Boerwinkle E, Saha N, et al. Apol-poprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo(a) gene in coronary heart disease. J Clin Invest 1992; 89:1040.
51. Pang RWC, Janus ED, Lam KSL. Levels of plasma apolipoprotein(a) in a Hong Kong Chinese population [abstract] Asian Pacific Congress on Lipid Risk Factor Control, Hong Kong, 1994:57.
52. Marcovina SM, Zhang ZH, Gaur VP, et al. Identification of 34 apolipoprotein(a) alleles between American Blacks and Whites. Biochem Biophys Res Commun 1993; 191:1192.